Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: Fecal recovery following oral administration and safety

Canadian Veterinary Journal

Volumn 44, Issue 4, 2003, Pages 299-302

  Weese, J Scott ^a   Anderson, Maureen E C ^a   Lowe, Andrew ^a   Monteith, Gabrielle J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CAPSULE; DRUG MEGADOSE; DRUG SAFETY; DRUG SCREENING; FECES ANALYSIS; FECES LEVEL; HORSE; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; NONHUMAN; TIME;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; BACTERIAL ADHESION; COLONY COUNT, MICROBIAL; DIGESTIVE SYSTEM; FECES; HORSE DISEASES; HORSES; LACTOBACILLUS; PROBIOTICS; RANDOM ALLOCATION; SAFETY;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

EID: 0037853354     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998;39:237-238.
2. Metchnikoff E. The Prolongation of Life, London. William Heinemann 1907.
3. Reid G. In defense of probiotics. ASM News 2000;66:261.
4. Parraga ME, Spier SJ, Thurmond M, Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the postoperative period in horses with colic. J Vet Int Med 1997;11:36-41.
5. Kim L, Morley PS, Traub-Dargatz JL, Salman MD, Gentry-Weeks C. Factors associated with Salmonella shedding among colic patients at a veterinary teaching hospital. J Am Vet Med Assoc 2001;218:740-748.
6. Fuller R. Probiotics in human medicine. Gut 1991;32:439-442.
7. Filho-Lima JVM, Vieira EC, Nicoli JR. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. J Appl Microbiol 2000;88:365-370.
8. McFarland LV, Surawicz CM, Greenburg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271:1913-1918.
9. Dunne C, O'Mahoney L, Murphy L, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001;73:386S-392S.
10. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78:80-88.
11. Ouwehand AC, Niemi P, Salminen SJ. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro. FEMS Microbiol Lett 1999;177:35-38.
12. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000;95:S1-S4.
13. Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 2000;130:391S-395S.
14. Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotech 2000;84:197-215.
15. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (Strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-128.
16. Alander M, Satokari R, Korpela R, et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Env Microbiol 1999;65:351-354.
17. Saxelin M, Ahokas M, Salminen S. Dose response on the faecal colonisation of Lactobacillus strain GG administered in two different formulations. Microbiol Ecol Health Dis 1993;6:119-122.
18. Saxelin M, Elo S, Salminen S, Vapaatalo H. Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG. Microbiol Ecol Health Dis 1991;4:209-214.
19. Armuzzi A, Cremonin F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001;63:1-7.
20. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999;134:15-20.
21. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000;95:S16-S18.
22. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999;135:564-568.
23. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990;22:53-56.
24. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter Euopean trial. J Pediatr Gastrenterol Nutr 2000;30:54-60.
25. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995;14:107-111.
26. Isolauri E, Juntunen M, Pautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-97.
27. Lee DJ, Drongowski RA, Coran AG, Harmon CM. Evaluation of probiotic treatment in a neonatal animal model. Pediatr Surg Int 2000;16:237-242.
28. Saxelin M, Pessi T, Salminen S. Fecal recovery following oral administration of Lactobacillus Strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 1995;25:199-203.
29. Anonymous. SAS/STAT Software: changes and enhancements through release 6.12, Cary, North Carolina, USA.
30. Campbell ML, Ackerman N, Peyton LC. Radiographic gastrointestinal anatomy of the foal. Vet Radiol 1984;25:194-204.